AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
Monday cybersecurity recap on evolving threats, trusted tool abuse, stealthy in-memory attacks, and shifting access patterns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results